# A Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19

> **NCT07269587** · — · ACTIVE_NOT_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 275 (actual)

## Conditions studied

- ALL (Acute B-Lymphoblastic Leukemia)
- CAR-T Cell Therapy

## Interventions

- **DRUG:** CNCT-19

## Key facts

- **NCT ID:** NCT07269587
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-11-07
- **Primary completion:** 2027-11-30
- **Final completion:** 2027-11-30
- **Target enrollment:** 275 (ACTUAL)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07269587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07269587, "A Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT07269587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*